Safe-by-Design Strategies for Intranasal Drug Delivery Systems: Machine and Deep Learning Solutions to Differentiate Epithelial Tissues via Attenuated Total Reflection Fourier Transform Infrared Spectroscopy
- PMID: 40109738
- PMCID: PMC11915033
- DOI: 10.1021/acsptsci.4c00643
Safe-by-Design Strategies for Intranasal Drug Delivery Systems: Machine and Deep Learning Solutions to Differentiate Epithelial Tissues via Attenuated Total Reflection Fourier Transform Infrared Spectroscopy
Abstract
The development of nasal drug delivery systems requires advanced analytical techniques and tools that allow for distinguishing between the nose-to-brain epithelial tissues with better precision, where traditional bioanalytical methods frequently fail. In this study, attenuated total reflection Fourier transform infrared (ATR-FTIR) spectroscopy is coupled to machine learning (ML) and deep learning (DL) techniques to discriminate effectively between epithelial tissues. The primary goal of this work was to develop Safe-by-Design models for intranasal drug delivery using ex vivo pig tissues experiment, which were analyzed by way of ML modeling. We compiled an ATR-FTIR spectral data set from olfactory epithelium (OE), respiratory epithelium (RE), and tracheal tissues. The data set was used to train and test different ML algorithms. Accuracy, sensitivity, specificity, and F1 score metrics were used to evaluate optimized model performance and their abilities to identify specific spectral signatures relevant to each tissue type. The used feedforward neural network (FNN) has shown 0.99 accuracy, indicating that it had performed a discrimination with a high level of trueness estimates, without overfitting, unlike the built support vector machine (SVM) model. Important spectral features detailing the assignment and site of two-dimensional (2D) protein structures per tissue type were determined by the SHapley Additive exPlanations (SHAP) value analysis of the FNN model. Furthermore, a denoising autoencoder was built to improve spectral quality by reducing noise, as confirmed by higher Pearson correlation coefficients for denoised spectra. The combination of spectroscopic analysis with ML modeling offers a promising strategy called, Safe-by-Design, as a monitoring strategy for intranasal drug delivery systems, also for designing the analysis of tissue for diagnosis purposes.
© 2025 The Authors. Published by American Chemical Society.
Conflict of interest statement
The authors declare no competing financial interest.
Similar articles
-
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23. Clin Orthop Relat Res. 2024. PMID: 39051924
-
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3. Cochrane Database Syst Rev. 2022. PMID: 35593186 Free PMC article.
-
Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.Cochrane Database Syst Rev. 2022 Jul 22;7(7):CD013705. doi: 10.1002/14651858.CD013705.pub3. Cochrane Database Syst Rev. 2022. PMID: 35866452 Free PMC article.
-
The educational effects of portfolios on undergraduate student learning: a Best Evidence Medical Education (BEME) systematic review. BEME Guide No. 11.Med Teach. 2009 Apr;31(4):282-98. doi: 10.1080/01421590902889897. Med Teach. 2009. PMID: 19404891
-
Systemic and topical antibiotics for chronic rhinosinusitis.Cochrane Database Syst Rev. 2016 Apr 26;4(4):CD011994. doi: 10.1002/14651858.CD011994.pub2. Cochrane Database Syst Rev. 2016. PMID: 27113482 Free PMC article.
References
-
- Katare P.; Medhe T. P.; Nadkarni A.; Deshpande M.; Tekade R. K.; Benival D.; Jain A. Nasal Drug Delivery System and Devices: An Overview on Health Effects. ACS Chem. Health Saf. 2024, 31 (2), 127–143. 10.1021/acs.chas.3c00069. - DOI
-
- Ladel S.; Schlossbauer P.; Flamm J.; Luksch H.; Mizaikoff B.; Schindowski K. Improved in Vitro Model for Intranasal Mucosal Drug Delivery: Primary Olfactory and Respiratory Epithelial Cells Compared with the Permanent Nasal Cell Line RPMI 2650. Pharmaceutics 2019, 11 (8), 36710.3390/pharmaceutics11080367. - DOI - PMC - PubMed
LinkOut - more resources
Miscellaneous